• Username (E-mail)
  • Password
Dow 21,141 1.6%  EStoxx50 3,390 2.1%  Nikkei 19,394 1.4%  EUR 1.0551 -0.2% 
Nasdaq 5,905 1.4%  FTSE100 7,383 1.6%  Yen 113.6540 0.7%  Oil 56.4 1.5% 
S&P500 2,398 1.4%  DAX 12,067 2.0%  GBP 1.2292 -0.7%  Gold 1,250 0.1% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

Profile Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Shareholder

Owner in %
Freefloat99.45
T. Rowe Price Associates, Inc.8.80
Capital Research & Management Co. (World Investors)8.36
Fidelity Management & Research Co.7.86
The Vanguard Group, Inc.6.41
Wellington Management Co. LLP6.01
BlackRock Fund Advisors5.38
SSgA Funds Management, Inc.4.74
ClearBridge Investments LLC3.48
Columbia Management Investment Advisers LLC3.13
JPMorgan Investment Management, Inc.2.96
Waddell & Reed Investment Management Co.1.55
Goldman Sachs Asset Management LP1.22
Northern Trust Investments, Inc.1.07
Ivy Investment Management Co.1.03

Address

50 Northern Avenue, 02210 Boston
Postofficebox:
Telephone: 16173416100
Fax:
Internet: http://www.vrtx.com
E-mail:

Management

Jeffrey M. Leiden MD, PhDStuart A. Arbuckle
Jeffrey A. Chodakewitz, MDDavid Matthew Altshuler MD, PhD
Joshua S. Boger, PhDMichael J. Parini
Ian F. SmithZachry Barber
Margaret G. McGlynn, MBATerrence C. Kearney, MBA
Yuchun Lee, MBAWilliam D. Young MBA, PHD
Sangeeta N. Bhatia MD, PhDBruce I. Sachs, MBA
Elaine S. UllianSimon Bedson, MBA
Michael J. LaCasciaAmit K. Sachdev
Paul M. SilvaG. Michael Palladino
Dawn KalmarMichael Partridge

Board of Directors

Add or Edit Instrument